LRRK2 and Parkinson disease: These findings facilitated additional studies in patient cohorts, which have consistently found elevated levels of di-22:6 BMP and other BMP isoforms in urine from LRRK2 mutation carriers, both manifesting and non-manifesting for PD [72–74].